Nanjing Yaoshi Pharmaceutical R&D Co., Ltd. was established in 2006 and officially started operation in September 2008. It is an emerging high-tech biopharmaceutical R&D company.
Nanjing Yaoshi Drug R&D Co., Ltd. leverages its unique chemical reagent platform and R&D team’s advantages in synthetic chemistry, computational chemistry and medicinal chemistry to carry out chemical R&D with international drug R&D companies including Roche. Outsourcing FTE services. At present, the company's R&D capabilities and continuous innovation capabilities are already at the forefront of the domestic biopharmaceutical R&D industry. For example, the company has become a leader in azetidine, oxetane and cyclobutane products as well as products based on azetidine, The world's leading supplier of new spirocyclic products with oxetane and cyclobutane structures. We have provided several well-known domestic and foreign pharmaceutical companies such as Pfizer, Aboot, Roche, Novartis, Gilead, Takeda, Teva, etc. with a single purchase amount of several times. A hundred thousand dollar product.
In 2011, the company successively won the honorary titles of the most promising entrepreneurial enterprise in the 100 Entrepreneurship Centers for Chinese Overseas Students and the Advanced Technology Service Enterprise in Nanjing.